Allowing you to make negative fluffy premonitions on appearances, ok - but this is all that this is & you’ve just swung in to downramp.
“I would say “ . ..,
”best one might hope for “ .., then to purport an out of thin air statement to effect to say that the stock is going to go to low again.
“better come up with a significant improvement in operations “…, “to remedy failed promises”
These just unfair . No care for what required and managing rollout US and global use Sozo and tech.
Also for broader larger indications.
In any case you write just a word salad.
Just writing words off top of your head. On weakness you have come in to take a bash at the show.
Sounding negative and sage. Maybe even thinking you’ll buy on a nice dump low if sentiment can get down and a bad day occur. Not nice though.
I don’t think actually that you have a great understanding of the company or it’s fully FDA approved and required monitoring care for oncology patients and post - cancer survival.
It’s a process but the diagnostic care is now in the guidelines of care, is a duty of care also- to monitor for and prevent lymphoedema.
It is only time.
Whether ImpediMed fully manifests or it gets taken over maybe right when all the hard work mostly done.
IPD shareholders been through a lot.
But small caps have been getting beaten. The big indexes catching all the main money flows and action.
Development biotech is having a pullback right now but I think still time to rally into Christmas.
Then also into end of the first quarter next year.
Which has been always when traction has been expected , at long last, due to delays and processes with US hospitals budgets and onboarding and protocols to be determined.
Can expect that it has to happen however.
Add to My Watchlist
What is My Watchlist?
